The Connection Domain Mutation N348I in HIV-1 Reverse Transcriptase Enhances Resistance to Etravirine and Rilpivirine but Restricts the Emergence of the E138K Resistance Mutation by Diminishing Viral Replication Capacity

Clinical resistance to rilpivirine (RPV), a novel nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI), is associated an E-to-K mutation at position 138 (E138K) in RT together with an M184I/V mutation that confers resistance against emtricitabine (FTC), a nucleoside RT inhibitor (NRTI) that is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Xu, Hong-Tao, Colby-Germinario, Susan P., Oliveira, Maureen, Han, Yingshan, Quan, Yudong, Zanichelli, Veronica, Wainberg, Mark A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3911599/
https://ncbi.nlm.nih.gov/pubmed/24227862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02904-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados